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Abstract
The diagnosis of Henoch-Schönlein purpura (HSP) is difficult, especially when abdominal symptoms precede
cutaneous lesions.
We report three cases of adult HSP revealed by gastrointestinal (GI) involvement.
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Introduction
Henoch Schonlein purpura (HSP) is a leucocytoclastic
vasculitis involving small vessel with deposition of
immune Ig A complexes. HSP primarily affects children,
(approximately 15 cases/100.000 per year) [1]. It is less
common among adults. Clinically, HSP is characterized
by palpable purpura, arthritis, renal and gastrointestinal
involvement. Among adults, the incidence of HSP, the
clinical features and the severity seems to be different
compared to children [2]. Except for potential intestinal
complications, its prognosis is usually excellent. How-
ever, nephritis is another complication that might have
less prognosis. We report three cases of adult-onset
HSP revealed by gastrointestinal (GI) involvements.
Case reports
Over a period of 2 years (2009-2010), three patients
with adult-onset HSP were admitted to Department of
Internal Medicine. The clinical profiles, along with
laboratory and radiological data, of the three patients
a r es h o w ni nT a b l e1 .G Ii n v o l v e m e n t sw e r et h ef i r s t
symptoms in the 3 cases. The delay between the GI
involvement and the others symptoms is shown in table
1. Skin biopsy showed leucocytoclastic vasculitis with Ig
A and C3 deposits in direct immunofluorescence (DIF)
in the 3 cases.
The oesogastroduodenal endoscopy with biopsy
showed the presence of helicobacter pylori in case 1 and
2. The rapid urease tests for Helicobacter pylori was not
done.
In the first case, the colonoscopy showed the presence
of colic poliposis with moderate dysplasia on the biopsy.
Tumor markers (ACE, AFP, PSA, Ca-19-9) were nega-
tive. The kidney biopsy revealed “Extracapillar glomeru-
lonephritis with Ig A depositis in DIF) and the patients
received 6 monthly cyclophosphamide pulse.
Our second patient presented initially with acute
appendicitis confirmed by the histological finding. There
was no depositis in the DIF.
All the patients had complete recovery from their
abdominal symptoms within approximately three weeks.
Discussion
HSP usually presents with a classic tetrad of rash, poly-
arthralgias, abdominal pain and renal disease. The clini-
cal presentation of HSP is more severe among adult and
tends to be atypical: higher rate of severe and atypical
GI problems and delayed renal complications [3].
Older patients showed much more severe renal and
extra-renal manifestations than younger patients in
which the joint manifestations appear to be the most
frequent. However, the severe GI involvements are less
common in adults than children [4,5]. The mechanism
of GI involvement in HSP may include IgA deposits on
small vessel wall and polymorphonuclear neutrophils
(PMNs) infiltration around vessels [3].
It occurs in 50- 75% of adult patients [6].
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with the diagnosis of HSP, GI were found in 90 patients
(78.2%). [7]; it was 24% in the study of Novak et all [8]
In a large Italian cohort of 250 patients, adults and
children, with HSP, necrotic purpura was present in
96% of the cases, arthritis in 61% of the cases and GI
involvement in 48% of cases. The main symptom was
colicky abdominal pain. Bleeding occurred in 51% cases
of GI involvement and was serious, requiring transfusion
or surgery or leading to death in 11% of the cases [9].
In the retrospective study conducted by Chang and all,
including 261 children with a diagnosis of HSP, 151
(58%) had abdominal pain and 46 (17.6%) had GI bleed-
ing detected as positive stool occult blood. Seven
patients had gross bloody stools [10].
When comparing 82 children and 20 adults with HSP,
Uppal and all found that the frequency nausea, vomit-
ing, malena/hematochezia and intussusception were the
Table 1 Clinical, demographic and laboratory findings of the 3 patients
Feature Case 1 Case 2 Case 3
Age (years)/Gender 62/F 20/M 66/M
GI involvment Hematemesis/abdominal pain Severe abdominal pain/vomitting Colicky abdominal pain/vomiting.
Skin rash Lower limb and abdomen Lower limb Lower limb
Joints involved Joint tenderness Arthritis of the knee and ankles arthritis of the ankle
Delay between GI
involvement and
other symptoms
3 weeks 4 weeks 2 weeks
Haemoglobin (g/dL) 10.3 15.6 14.7
Total leucocyte
count (/μL)
13.000 10.400 12.200
Platelet count (/μL) 343.000 360.000 371.000
ESR (mm/1st hour) 45 22 37
Urine microscopy Microscopc hematuria Normal Normal
24-hour urinary
proteins
3.3 gr Nil Nil
Renal function Normal Normal Normal
occult blood stool
tests
positive Not done negative
Colonoscopy colic poliposis with moderate dysplasia on
the biopsy.
Not done Not done
CT of the abdomen Not done Normal Not done
Skin biopsy Leucocytoclastic vasculitis
DIF: Ig A
Leucocytoclastic vasculitis
DIF: Ig A/C3
Leucocytoclastic vasculitis
DIF: Ig A/C3
Oesogastroduodenal
endoscopy/Biopsy
Cardial ulcer with stigmata of bleeding
and purpuric lesions of the bulb and the
duodenum/presence of leucocytoclastic
vasculitis with intestinal metaplasia and
Hp gastritis
Antrite congestive with purpuric lesions of
the bulb and the duodenum/presence of
leucocytoclastic vasculitis with chronic and
moderately active Hp antral gastritis
Purpuric lesions of the bulb and
ulcers of the DI and DII portion of
the bulb/erosive duodenitis and
leucocytoclastic vasculitis 1
Kidney biopsy Extracapillar glomerulonephritis with Ig A
depositis in DIF
Not done Not done
treatment Methylprednisolone pulse (1 g/day × 3
days) + oral prednisolone associated with
cyclophosphamide pulse
Colchicine
®
PPI
Colchicine
®
PPI
Outcome Complete recovery Complete recovery Complete recovery
ESR: erythrocyte sedimentation rate; HPE: histopathology; DIF: direct immunofluorescence; GI: Gastrointestial ; PPI: proton pump inhibitors; Hp: Helicobacter pylori
 
Figure 1 Leucocytoclasic vasculitis of the duodenum.
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diarrhea [11].
When studying 46 adults and 116 children with HSP,
Blanco and all reported a higher incidence of renal (p <
i0.001) and lower GI involvement at disease onset in
adult HSP, but during the clinical course, GI involve-
ment was the same in both age groups [12].
Trouiller and all tried to assess a score of severity pro-
posed to use clinical and radiological (CT scan) severity
scores to assess the usefulness and the efficacy of corti-
costeroid therapy. The authors conclude, by styding 34
cases of patients with HSP, 68% of them with GI invol-
vement, that these results suggest that corticosteroids
may reduce abdominal symptoms of HSP in adults with
clinically severe disease [13].
In rare cases, GI involvements revealed HSP, as in our
3 patients. It was reported by Farah [14] and Moles [15].
Al Toma and all described a case of a 40- year’so l d
man who presented with terminal ileitis complicated by
thrombotic microangiopathy revealing HSP [16].
GI was the first manifestation of HSP in 11% of the
patients of Trappani [17] and 8% of those of Coppo [8].
Another important retrospective study was performed
by Chen and Kong including 161 patients; colicky
abdominal pain was noticed in 98.1% and vomiting in
39.5% of the patients. In 25 (3%) of the reported cases,
GI symptoms were manifested before skin rash [18].
The classic findings may consist in: Periumbilical
colicky and abdominal pain (related to edema, bleeding),
nausea, vomiting, diarrhea, constipation, abdominal dis-
tension which are usually mils and rarely severe enough
to be confused with an acute abdomen leading to lapar-
otomy. Rare GI manifestations may include: Intestinal
perforation, ischemic vasculitis, intussusceptions, eso-
phageal ulcers, pancreatitis, pseudomembranous colitis,
extensive GI bloodloss requires hemodynamic monitor-
ing, transfusion and occasionally emergent surgical
intervention, appendicitis, massive bowel necrosis. Mas-
sive GI hemorrhage and grossly bloody or melanotic
stools are respectively reported in 2% and 30% of the
patients [13,19-22]. Simultaneous occurrence HSP and
acute appendicitis is rarely observed, as in our second
case [23].
Mucosal lesions develop anywhere within the GI tract.
Diffuse mucosal redness, small ring-like petechiae and
hemorrhagic erosions are characteristic endoscopic find-
ings. The small intestine is considered to be the most
frequently affected site. Duodenal involvement was more
prominent in the second part of the duodenum than in
the bulb [24].
Imaging studies consisting in abdominal X -ray film,
abdominal echography, and abdominal CT, and stool
occult blood tests are important examinations [10].
Laparotomy which is performed in approximately 10% is
useful when esophagogastroduodenoscopy, colonoscopy
and small bowel barium radiogram show normal results.
Videocapsule endoscopy represents a unique improve-
ment in the investigation of intestinal diseases, allowing
an excellent visualization of the mucosa of the small
bowel [25].
Malignancy also has been reported as a rare causative
factor of HSP [26]. The recent retrospective study con-
ducted by Mitsui and all found 53 cases of malignant
tumors [27]. Our first patient had colic dysplasia. No
previous association has been reported so far.
Helicobacter pylori (Hp) infection may be associated
with the development and relapse of HSP with gastroin-
testinal involvement among children; Wang found that
21 of 36 HSP patients with GI manifestations were con-
firmed with Hp infection (58.3%). Among those patients,
t h er e l a p s e dp a t i e n t sh a daH pp o s i t i v er a t eo f8 1 . 3 %
(13/16), which was significantly higher than the newly
diagnosed patients (45.0%, 9/20; P < 0.05). Two of our
patients had Hp infection at the moment of the diagno-
sis [28].
When studying 11 adult patients with HSP and 20
healthy subjects, Novak concluded that IgG antibodies
to Hp may be present mostly in acute HSP, while IgA
antibodies may be involved in sustaining GI symptoms
underlying the chronic phase of the disease [29].
The cutaneous pathology of Hp is far from being
clear, but it is speculated that the systemic effects may
involve increased mucosal permeability to alimentary
antigens, immunomodulation, an autoimmune mechan-
ism or the impairment of vascular integrity [30].
Recently, polymorphism at codon 469 of the intercel-
lular adhesion molecule-1 (ICAM-1) locus has been
associated with protection against severe gastrointestinal
complications in HSP [31].
In most cases, HSP spontaneously disappears without
treatment. The use of corticosteroids is controversial and
usually reserved for severe systemic manifestations [32].
Steroid treatment makes improvement in the GI
symptoms at an early stage but does not prevent the
recurrence of abdominal pain attacks. Steroids decrease
the intestinal wall edema and thus the symptoms
improve or disappear.
In a Randomized, Double-Blind, Placebo-Controlled
Trial, including 171 patients with HSP, Prednisone was
effective in reducing abdominal pain (p = 0,028); the
incidence of severe abdominal pain necessitating hospi-
tal admission was greater in the placebo group than in
the prednisone group [33]. These data are in keeping
with those of Peru and all; these authors conclude that
the steroid treatment given to HSP patients with GI
manifestations might be helpful to prevent probable
complications such as bleeding and intussusceptions
[34].
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very beneficial on GI involvement.
Colchicina can be used in the treatment of HSP
[35,36]. The rationale for using colchicine to treat HSP
is based on the fact that colchicine perturbs microtubule
function of the polymorphonuclear cell cytoskeleton
[37]. This results in inhibition of polymorphonuclear
cell migration to the site of inflammation.
Conclusion
GI involvements are frequent in HSP. The diagnosis is
more difficult when they precede the other manifesta-
tions and especially the cutaneous rash. Treatments are
still controversial.
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